Literature DB >> 18318676

The results of Hodgkin lymphoma treatment in children in the period 1997-2006.

Edo Hasanbegović1, Snijezana Sabanović.   

Abstract

In this paper we present the study of chemotherapy and radiotherapy treatment success in children suffering from Hodgkin's disease (HD) that were treated at Hematology-oncology Department of Pediatric Clinic in Sarajevo. In retrospective study we followed all patients with HD aged 0-15 who were diagnosed with and treated for HD at Pediatric Clinic in Sarajevo over the last 10 years (1st of January 1997 - 31st of December 2006). Until 2000 we used combination of chemotherapy and radiotherapy according to UKCCSG HD 9201 treatment protocol, and after the year 2000 protocol UKCCSG HD 2000 (ChlVPP / ABVD) was applied. The total number of the treated children 33. There were 17 boys (51,51 %) and 16 girls (48,49 %). In 10 patients (30,3 %) we found II A stage of HD, in 4 (12,1 %) II B stage of HD, in 6 children (18,8 %) stage III A, in 4 children (12,1 %) stage III B, in 4 children (12,1 %) stage IV A and in 5 (15,1 %) stage IV B. In 7 patients (21,2 %) relapse occurred, which demanded more aggressive chemotherapeutic treatment and radiotherapy too; while for 4 patients (12,1 %) in combination with bone marrow transplantation. Three patients (9,0 %) died. There are 30 children (91,0 %) who are alive and in either 1st or 2nd remission phase of HD. Secondary malignancies did not occur in any of the patients. Although many patients (58,1%) were diagnosed in an advanced stage of illness (III and IV) the results of HD therapy at Pediatric Clinic in Sarajevo are comparable to those in other European centers.

Entities:  

Mesh:

Year:  2008        PMID: 18318676      PMCID: PMC5724880          DOI: 10.17305/bjbms.2008.3001

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  8 in total

Review 1.  Treatment of paediatric Hodgkin's disease. a balance of risks.

Authors:  A B Thomson; W H B Wallace
Journal:  Eur J Cancer       Date:  2002-03       Impact factor: 9.162

2.  Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.

Authors:  T G Sagar; Anita Chandra; S G Raman
Journal:  Med Pediatr Oncol       Date:  2003-01

3.  A selective history of the therapy of Hodgkin's disease.

Authors:  Vincent T DeVita
Journal:  Br J Haematol       Date:  2003-09       Impact factor: 6.998

4.  Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.

Authors:  Saunders C Hsu; Monika L Metzger; Melissa M Hudson; Francisco Pedrosa; Mecneide Lins; Marcia Pedrosa; Cynthia Barros; Kaline Maciel; Ching-Hon Pui; Raul C Ribeiro; Scott C Howard
Journal:  Pediatr Blood Cancer       Date:  2007-08       Impact factor: 3.167

Review 5.  What causes Hodgkin's disease in children?

Authors:  C A Stiller
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

Review 6.  Present and future strategies of treatment in childhood Hodgkin's lymphomas.

Authors:  O Oberlin
Journal:  Ann Oncol       Date:  1996       Impact factor: 32.976

Review 7.  Radiotherapy versus combined modality in early stages.

Authors:  L Specht; P Carde; P Mauch; S M Magrini; M T Santarelli
Journal:  Ann Oncol       Date:  1992-09       Impact factor: 32.976

Review 8.  Pediatric Hodgkin's disease: treatment in the late 1990s.

Authors:  G Schellong
Journal:  Ann Oncol       Date:  1998       Impact factor: 32.976

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.